Dynavax Technologies (DVAX) 10-Q2006 Q1 Quarterly report

Filed: 5 May 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Add, administered, adult, affiliated, AG, age, aged, anniversary, antiviral, approach, arm, behavior, beneficiary, CIBC, complement, complementary, coordination, Crucell, curve, daily, DARTT, database, decide, decided, denominator, direct, diversion, Dr, Dynamo, efficiently, elicit, enterprise, entity, EU, European, FIN, forfeiture, foundation, fully, Germany, GmbH, goal, hold, indistinguishable, industrial, infection, input, insufficient, intangible, integrate, integrating, integration, Interpretation, issuable, jointly, judgment, level, LLC, LP, multifaceted, Note, numerator, NV, Pacific, payable, peer, placebo, potent, profile, pronouncement, prospectively, randomized, rapidly, reconciliation, reconsideration, reduction, repurchase, reserved, residual, restated, Rhein, Rituxan, RRD, side, site, solid, stronger, structure, structuring, SUPERVAX, supplement, Symphony, Theravax, timeline, transient, treasury, tumor, Union, unknown, unrecognized, usage, valuation, variability, variable, VIE, warrant, World

Removed: achieving, Acquiring, added, adjusting, amended, audit, beneficially, binomial, Bulletin, clear, committee, compute, defend, director, discover, durable, earliest, earned, EITF, exceeded, excluded, exist, expansion, growing, healthcare, healthy, HIV, inclusion, indemnification, indemnified, induced, interaction, lifetime, measured, measuring, methodology, policy, positive, predicted, proven, published, quickly, reevaluating, reflected, reflecting, reimbursable, relationship, replacement, representative, reverse, reversed, robust, rose, SAB, secondary, select, Selling, serving, settle, suffered, surrendered, survive, trend, typically, underlying, underserved, unlimited, unvested, upfront, variance

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

DVAX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification Pursuant to Section 1350 of Chapter 63
of Title 18 of the United States Code

I, Deborah A. Smeltzer, hereby certify, pursuant to 18 U.S.C § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, in my capacity as an officer of Dynavax Technologies Corporation (the “Company”), that, to the best of my knowledge:

	(iii)		The Quarterly Report of the Company on Form 10-Q for the period ended March 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

	(iv)		The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 5, 2006	By:	/s/ DEBORAH A. SMELTZER

		Deborah A. Smeltzer Vice President, Operations and Chief Financial Officer (Principal Financial Officer)